Keyword: Eli Lilly


Isomorphic Labs to Collaborate with Eli Lilly and Novartis

10.01.2024 -

Isomorphic Labs announced strategic collaborations with leading pharmaceutical companies, Eli Lilly and Company and Novartis. These partnerships have the potential to be...


Lilly Completes $1.4 Billion Acquisition of Point Biopharma

03.01.2024 -

US drug manufacturer Eli Lilly has completed its acquisition of radiopharmaceutical company Point Biopharma for approximately $1.4 billion.


Lilly Invests in New $2.5 Billion Production Site in Germany

17.11.2023 -

Lilly announced today that it plans to invest €2.3 billion ($2.5 billion) in the construction of a new high-tech manufacturing facility in Alzey, Germany. The company...


Eli Lilly to Acquire Radiopharmaceutical Company Point Biopharma for $1.4 Billion

04.10.2023 -

Eli Lilly announced that it is acquiring radiopharmaceutical company Point Biopharma for $12.50 per share in cash, valuing the deal at approximately $1.4 billion. Point...


Lilly to Acquire Obesity Drug Maker Versanis

17.07.2023 -

Major drugmaker Eli Lilly has agreed to acquire Versanis Bio, a privately held obesity drug maker, for up to $1.925 billion. The transaction is subject to customary...


Lilly Boosts Immunology with Dice Buy

22.06.2023 -

Major drugmaker Eli Lilly is to pay up to $2.4 billion to acquire Dice Therapeutics, a US biotech specializing in developing oral medicines to treat chronic autoimmune...

Markets & Companies

Navigating Uncertainty in the Biopharma Market

17.05.2023 -

Biopharma companies are facing funding challenges in 2023 as interest rates rise and investors are becoming more risk adverse. There is hope on the horizon, say some...


Big Pharma Undercuts California Generic Insulin Plan

29.03.2023 -

Plans by major insulin producers Eli Lilly, NovoNordisk and Sanofi to drop their prices may be undercutting the US state of California’s state-backed generic insulin...